Picture of Acura Pharmaceuticals logo

ACUR Acura Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Acura Pharmaceuticals Inc Receives $200,000 Loan From Abuse Deterrent Pharma

July 13 (Reuters) - Acura Pharmaceuticals Inc  ACUR.PK :
    * ACURA PHARMACEUTICALS INC - ON JULY 10, 2023, RECEIVED A
$200,000 LOAN FROM ABUSE DETERRENT PHARMA
    * ACURA PHARMACEUTICALS INC - FUNDING PROVIDED BY AD PHARMA
WILL
BE USED FOR OPERATIONS THROUGH MID-AUGUST 2023
    * ACURA PHARMACEUTICALS - IN ABSENCE OF RECEIPT OF
ADDITIONAL
FINANCING BY MID-AUGUST 2023, WE WILL BE REQUIRED TO SCALE BACK
OR TERMINATE OPERATIONS
    * ACURA PHARMACEUTICALS - IN ABSENCE OF RECEIPT OF
ADDITIONAL
FINANCING BY MID-AUGUST , MIGHT BE REQUIRED TO SEEK PROTECTION
UNDER BANKRUPTCY LAWS
    * ACURA PHARMACEUTICALS INC - AT JULY 1, 2023, AD PHARMA
DIRECTLY
OWNS APPROXIMATELY 66% OF OUTSTANDING COMMON STOCK OF COMPANY

Further company coverage:  ACUR.PK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Acura Pharmaceuticals

See all news